M&A Deal Summary |
|
|---|---|
| Date | 2013-10-14 |
| Target | Vet Therapeutics |
| Sector | Life Science |
| Buyer(s) | Aratana Therapeutics |
| Deal Type | Add-on Acquisition |
| Deal Value | 30M USD |
SEARCH BY
| Category | Company |
|---|---|
| Founded | 2010 |
| Sector | Life Science |
| Employees | 83 |
| Revenue | 35M USD (2018) |
Aratana Therapeutics, Inc. is a biopharmaceutical company focused on the licensing, development and commercialization of innovative medications for pets, or pet therapeutics. Aratana Therapeutics, Inc. was formed in 2010 and is headquartered in Leawood, Kansas.
| DEAL STATS | # |
|---|---|
| Overall | 1 of 2 |
| Sector: Life Science M&A | 1 of 1 |
| Type: Add-on Acquisition M&A Deals | 1 of 2 |
| State: California M&A | 1 of 1 |
| Country: United States M&A | 1 of 1 |
| Year: 2013 M&A | 1 of 1 |
| Size (of disclosed) | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2014-01-06 |
Okapi Sciences NV
Heverlee, Belgium Okapi Sciences NV is Belgium-based company with a proprietary pet therapeutics antiviral platform and five clinical/development stage candidates for treating important viral diseases. |
Buy | - |
